Products Recalled in 2021
S/N | Date recall was initiated | Product Name/ Product Category | INN Name (s) | Batch Number(s) | Name of Manufacturer | Reasons for recall |
1 | 10/05/2021 | Losar-Denk, | Lorsatan | All batches | Denk Pharma | Discovery of 4-chlor-azidomethyltetrazole |
2 | 10/05/2021 | Co-losar Denk | losartan and Hydrochlorthiazide | All batches | Denk Pharma | Discovery of 4-chlor-azidomethyltetrazole |
3 | 10/07/2021 | Tanzol 400mg | Albendazole | 371166 | Shalina Healthcare | The product failed dissolution test |
4 | 26/07/2021 | Dazole 1% | Clotrimazole | 1808208, 1901255, 1904237, 1904247, 1906123 | Dawa Ltd | Leaking contents |
5 | 06/08/2021 | Totomol suspension | Paracetamol | 78587 | Laboratory and Allied Ltd | Voluntary recall following crystallization |
6 | 25/08/2021 | Carbocysten-promethazine syrup | Carbocystein and promethazine | Several batches | Dawa Ltd | Voluntary recall due to fail of assay of FUST |
7 | 31/08/2021 | Frusemide 40mg | Frusemide | 2105115, 2105116 | Dawa Ltd | voluntary recall because of soft tablets |
8 | 27/09/2021 | Zolex 400 | Albendazole | ZOL803 |
| The product failed dissolution test |
9 | 06/10/2021 | Biotrim suspension | Trimethoprim suphamethoxazole | 520094 | Biodeal Laboratories Ltd | Color change |
10 | 21/10/2021 | Irbesatan finished products | Irbesartan | AA548, AA645, AA664, AA193, AA707, AMXA007, AMXA005, AMXA003, AMXA004, 9MXA005, | Sanofi Aventis | Potential presence of GTI2 |